COMBINATION CONTAINING N-(3-METHOXY-5-METHYLPYRAZINE-2-YL)-2-(4-[1,3,4-OXADIAZOL-2-YL]PHENYL)PURIDINE-3-SULPHONAMIDE AND LHRH-ANALOGUE AND/OR BIPHOSPHONATE

摘要

FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to medical products and concerns a combination for prostate cancer treatment containing effective amounts of N-(3-methoxy-5-methylpyrazine-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide or its pharmaceutically acceptable salt and pamidronate. There is also disclosed a method of prostate cancer treatment and application of the combination for preparing a medicinal agent used in prostate cancer treatment. ^ EFFECT: combination under the invention exhibits synergetic effect with respect to inhibiting metastases to bone and soft tissues in prostate cancer treatment. ^ 4 cl